Gerald L. Klein, MD is a board certified Allergist and Immunologist, and a board certified Pediatrician. He is an expert in Medical Affairs and Clinical Development and has published numerous scientific papers. He was a professor of Medicine and Pediatrics (Division of Basic and Applied Immunology) at University California, Irvine. Dr. Klein was a founder and CEO of Entera Health Inc., a biotherapeutics company. There, he created and managed both the clinical development and medical affairs programs. He was the Chief Medical Officer of Talecris/Grifols and he was also its VP of Medical and Clinical Affairs. During his tenure at Talecris, Dr. Klein was instrumental in creating a comprehensive safety and pharmacovigilance plan and helping the company gain a new neurological indication. Dr. Klein has also been CMO/VP Medical and Clinical Affairs at several specialty biopharmaceutical companies including: Dey/MerckKgAa: respiratory and allergy Clingenix: Pharmacogenomic (diabetes)/CRO; Specialty Labs/Pathway Diagnosis: Central and Specialty diagnostic laboratories; Oxygen Biotherapeutic/Tanex: Acute Brain Injury/Heart Failure. Dr. Klein began his career in industry by founding a CRO, San Diego Clinical Research Association, (SDCRA) where he served as CEO and CMO. SDCRA conducted studies in Dermatology, Infectious Disease, Neurology, Cardiology, Psychiatry, Nephrology, Pulmonology, Women’s Health, Surgery, and Allergy. SDCRA was sold to Quintiles, where Dr. Klein, was an SVP and worked in both Global Medical Affairs and Drug Development. Additionally, Dr. Klein has been on the Board of Directors of Nano Corp and Oxygen Biotherapeutics.